Synlait Milk Ltd (SM1)
Australian Securities Exchange · Australia · prices in AUD · close of 20 Oct 2026
Key indicators
| Last close | AUD 0.355 |
|---|---|
| 52-week range | 0.285 – 0.680 |
| Return, 1 month / 3 months | +18.3% / +12.7% |
| Return, 1 year / 3 years | −47.8% / −70.4% |
| Trend | Below its 200-day average |
| RSI (14) | 58 |
| Volatility (1 year) | 60.9% |
| Worst drawdown (1 year) | -57.5% |
| Average daily value traded | 0.01M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Synlait Milk is a dairy processor based in Canterbury, New Zealand. It collects milk from dairy farms and turns it into ingredients and finished products, including infant formula, milk powders and specialised dairy ingredients. Much of its output is made for other branded dairy companies under contract, and it also produces its own consumer dairy products. Its customers are food companies and consumers in New Zealand and in export markets such as Asia.
Synlait Milk Ltd trades under the code SM1 on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Synlait Milk Ltd (SM1) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.355 on 20 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 975 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 47.8% and over the last three months it rose 12.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -3.0% | ||
| From 52-week high | -47.0% | ||
| Momentum | 56 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 12.7% | ||
| 6-month return | 0.0% | ||
| 12-month return, skipping the last month | -55.9% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 60.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -57.5% | ||
| Liquidity | 19 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M AUD | ||
| Zero-volume days | 33.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −1.4% |
|---|---|
| 1 month | +18.3% |
| 3 months | +12.7% |
| 6 months | +0.0% |
| 1 year | −47.8% |
| 3 years | −70.4% |
| 5 years | −90.1% |
Signals
| 50-day / 200-day average | 0.328 / 0.366 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.013 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.